ClinConnect ClinConnect Logo
Search / Trial NCT06607081

Preoperative Risk Evaluation and Per ERAS Intervention in the Chinese Elderly Patients Underwent Spinal Fusion Surgery

Launched by XIJING HOSPITAL · Sep 19, 2024

Trial Information

Current as of July 05, 2025

Not yet recruiting

Keywords

Elderly Patients Eras Spinal Disease Surgical Intervention Risk Factors

ClinConnect Summary

This clinical trial is investigating how assessing preoperative risks and using specific care strategies (called ERAS measures) can help older patients who are having spinal fusion surgery. Spinal fusion is a procedure that helps treat serious back problems, particularly in people aged 75 and older who have degenerative spinal diseases and cannot be helped by other treatments. The aim is to see if these combined approaches can lead to better recovery and overall health after surgery.

To be eligible for the study, participants must be at least 75 years old and have specific back conditions that require surgery. They should also be able to understand and complete questionnaires, and they must agree to participate in the study. However, individuals with certain health issues, like severe heart or lung problems, recent strokes, or infections, will not be allowed to join. If eligible, participants can expect to undergo a thorough evaluation before surgery and receive focused care during their recovery to help improve their outcomes. The study is not yet recruiting participants, so it’s a chance for those who qualify to potentially benefit from enhanced care during their treatment.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1.Age ≥75 years old;
  • 2.Have degenerative spinal diseases, including cervical, thoracic and lumbar spine diseases;
  • 3.With severe neurological symptoms fail to conservative treatment and have to undergo the spinal fusion surgery;
  • 4.No serious cognitive impairment (MoCA score ≥8);
  • 5.No surgical contraindications;
  • 6.Anesthesia assessment patients can safely undergo surgery;
  • 7.Patients who voluntarily participate in and sign informed consent, can independently complete effective questionnaires, and are willing to follow up according to clinical requirements.
  • Exclusion Criteria:
  • 1.Patients who could not cooperate with doctors to complete preoperative evaluation and postoperative follow-up;
  • 2.Patients requiring spinal intervention due to spinal infection, fracture or metastatic disease;
  • 3.Patients with cerebrovascular accidents in the last 30 days;
  • 4.Patients with hepatic encephalopathy or acute active hepatitis;
  • 5.Patients with severe renal insufficiency with creatinine\>2.5mg/dL or undergoing hemodialysis;
  • 6.Patients with severe lung and cardiovascular diseases, coagulation disorders, and anesthesia contraindications;
  • 7.Patients with poorly controlled diabetes (HBAlc\>8.0%);
  • 8.Patients who are participating in clinical trials of other drugs or medical devices;
  • 9.Patients requiring emergency surgery;
  • 10.Patients who are considered by the investigator to be unable to participate in this clinical trial due to other circumstances.

About Xijing Hospital

Xijing Hospital, a prominent medical institution affiliated with the Fourth Military Medical University in Xi'an, China, is dedicated to advancing healthcare through innovative clinical research. Renowned for its comprehensive range of medical services and expertise in various specialties, Xijing Hospital actively sponsors clinical trials aimed at evaluating new therapies, improving patient outcomes, and contributing to scientific knowledge. With a commitment to ethical standards and patient safety, the hospital fosters collaboration among multidisciplinary teams to drive forward the development of effective treatment options that address critical health challenges.

Locations

Xi'an, Shaanxi, China

Xian, Shaanxi, China

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported